Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 778

1.

Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.

Cho SH, Kim SW, Kim WC, Park JM, Yoo IeR, Kim SH, Oh ST.

World J Gastroenterol. 2013 Jun 14;19(22):3453-8. doi: 10.3748/wjg.v19.i22.3453.

2.

Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

van Hoeij FB, Keijsers RG, Loffeld BC, Dun G, Stadhouders PH, Weusten BL.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):66-71. doi: 10.1007/s00259-014-2887-3. Epub 2014 Aug 20.

PMID:
25139518
3.

Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of advanced colorectal adenoma.

Gollub MJ, Grewal RK, Panu N, Thipphavong S, Sohn M, Zheng J, Moskowitz CS.

Clin Radiol. 2014 Jun;69(6):611-8. doi: 10.1016/j.crad.2014.01.009. Epub 2014 Feb 26.

PMID:
24581969
4.
5.

Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.

Treglia G, Calcagni ML, Rufini V, Leccisotti L, Meduri GM, Spitilli MG, Dambra DP, De Gaetano AM, Giordano A.

Colorectal Dis. 2012 Feb;14(2):174-80. doi: 10.1111/j.1463-1318.2011.02588.x. Review.

PMID:
21689289
6.

Positron emission tomography for the detection of colorectal adenomas.

Ravizza D, Bartolomei M, Santoro L, Tamayo D, Fiori G, Trovato C, De Cicco C, De Roberto G, Paganelli G, Crosta C.

Dig Liver Dis. 2010 Mar;42(3):185-90. doi: 10.1016/j.dld.2009.06.018. Epub 2009 Jul 29.

PMID:
19643688
7.

Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer.

Choi YJ, Kim MJ, Lee BH, Kwon MJ, Hwang HS.

Yonsei Med J. 2016 Jan;57(1):232-7. doi: 10.3349/ymj.2016.57.1.232.

8.

Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.

Fuertes J, Montagut C, Bullich S, Coma MI, Mestre-Fusco A, Suárez-Piñera M, Trampal C, Bellmunt J.

Rev Esp Med Nucl Imagen Mol. 2015 Mar-Apr;34(2):95-101. doi: 10.1016/j.remn.2014.07.008. Epub 2014 Sep 26.

9.

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.

J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.

PMID:
23278193
10.

Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.

Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z.

Colorectal Dis. 2011 Nov;13(11):e374-8. doi: 10.1111/j.1463-1318.2011.02727.x.

PMID:
21831098
11.

Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.

Lee JE, Kim SW, Kim JS, Choi KY, Kang WK, Oh ST, Yoo IeR, Kim SH.

World J Gastroenterol. 2012 Sep 28;18(36):5072-7. doi: 10.3748/wjg.v18.i36.5072.

12.

Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.

Farquharson AL, Chopra A, Ford A, Matthews S, Amin SN, De Noronha R.

Colorectal Dis. 2012 Feb;14(2):e56-63. doi: 10.1111/j.1463-1318.2011.02760.x.

PMID:
21831171
13.

The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.

Shi D, Cai G, Peng J, Li D, Li X, Xu Y, Cai S.

BMC Cancer. 2015 Dec 21;15:991. doi: 10.1186/s12885-015-1991-5.

14.

The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.

Hwang JP, Woo SK, Yoon SY, Jeong SY.

Ann Nucl Med. 2015 Feb;29(2):157-63. doi: 10.1007/s12149-014-0922-x. Epub 2014 Oct 31.

PMID:
25358843
15.

A comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up.

Huang SW, Hsu CM, Jeng WJ, Yen TC, Su MY, Chiu CT.

PLoS One. 2013 Jul 19;8(7):e69111. doi: 10.1371/journal.pone.0069111. Print 2013.

16.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458
17.

Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.

Ho TY, Liou MJ, Lin KJ, Yen TC.

Endocrine. 2011 Oct;40(2):297-302. doi: 10.1007/s12020-011-9470-5. Epub 2011 Apr 20. Erratum in: Endocrine. 2011 Oct;40(2):303.

PMID:
21505891
18.

[Diagnostic value of water enema (18)F-fluorodexyglucose positron emission tomography and computed tomography in incidental finding of hypermetabolism focus in the colorectum].

Zhang Z, Lyu Q, Chen F, Zhang J, Lu D, Hu P, Ma L.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Mar;17(3):239-44. Chinese.

PMID:
24671811
19.

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M.

Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10.

PMID:
23756383
20.

Supplemental Content

Support Center